Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process.

Source:http://linkedlifedata.com/resource/pubmed/id/17392390

Download in:

View as

General Info

PMID
17392390